A comprehensive rehabilitation policy would also be formulated to...
Category:
Health
Latest
Gambia hires US law firm to consider action on toxic Indian cough syrup, minister says
At least 70 children in Gambia, most under 5 years old, died from...
Shareholders to take call on listing: Future Generali India MD
India continues to be most attractive market for insurance players...
Pandemic plus social exclusion equals slide into poverty for millions in informal sector
While the virus affected all classes, the economic fallout of the COVID-19 pandemic was particularly devastating for those in the informal sector who found themselves on the streets, without their livelihoods and sometimes without their homes too.
PM Modi launches Ayushman Bharat scheme for all Jammu and Kashmir residents
The scheme will provide free-of-cost insurance cover to all residents of the UT of Jammu and Kashmir, the PMO said, adding that it will extend financial cover of up to Rs 5 lakh per family on a floater basis to all residents of the UT.
There is provision for operational extension of the ‘Pradhan Mantri Jan Arogya Yojana’ (PM-JAY) to approximately 15 lakh additional families, the PMO statement said, adding that the scheme will operate on insurance mode in convergence with PM-JAY.
Oxford Covid vaccine may be first to get govt nod for emergency use: Report
“Going by this, Oxford vaccine ‘Covishield’ is likely to be the first to be rolled out in India,” a source said.
The process of granting emergency use approval for Bharat Biotech’s COVID-19 vaccine ‘Covaxin’ may take time as its phase 3 trials are still underway, while Pfizer is yet to make a presentation.
Japan to ban new entries of foreigners until end-January – Nikkei
Japan on Friday reported its first cases of a fast-spreading variant in passengers arriving from Britain. The new variant has also been detected in a man who visited that country and a family member – the first cases of infected people found outside airport checks – Nippon TV reported on Saturday.
COVID-19 virus will stay with us for next 10 years: BioNTech CEO Ugur Sahin
“We need a new definition of normal. The virus will stay with us for the next 10 years,” he told mediapersons.
Pfizer COVID-19 vaccine causing more allergic reactions than expected
On Monday, a National Institute of Allergy and Infectious Diseases official said the US is looking at why some people have suffered severe allergic reactions shortly after Alkis Togias, chief of the NIAID’s Allergy, Asthma, and Airway Biology Branch, told CNBC that “several hundred people” who have a history of severe allergic reactions will be involved in a study.
SpiceJet signs MoU with GHAC for Covid-19 vaccine delivery from Hyderabad
“SpiceJet on its part will keep a dedicated fleet of freighters, including wide-body aircraft, at the Hyderabad airport to handle all domestic and international consignments,” the release added.
As part of this MoU, SpiceXpress – the cargo arm of SpiceJet – envisions to provide efficient, speedy and reliable solutions for vaccine delivery, while also creating a sustainable cold chain network, according to the release.
Govt plans dry run for Covid vaccine administration in 4 states next week
India has eight Covid-19 vaccine candidates, including three indigenous vaccines, under different stages of clinical trials which could be ready for authorization in near future.
It includes AstraZeneca and Oxford university developed and Serum Institute of India manufactured Covishield, Covaxin by Bharat Biotech Limited, ZyCoV-D by Zydus Cadila and Russian vaccine candidate Sputnik-V.
Scientists develop new gene therapy for deafness
“Children inheriting the defective gene from both parents are born with normal hearing, but they gradually lose their hearing during childhood. The mutation causes mislocalization of cell nuclei in the hair cells inside the cochlea of the inner ear, which serve as soundwave receptors and are essential for hearing. This defect leads to the degeneration and eventual death of hair cells,” said Professor Karen Avraham of the Department of Human Molecular Genetics and Biochemistry at TAU’s Sackler Faculty of Medicine and Sagol School of Neuroscience.
US doctor has severe allergic reaction to Moderna vaccine, says report
A US Food and Drug Administration (FDA) official said last week that the US drug regulator is investigating around five allergic reactions that occurred after people were administered Pfizer and BioNTech SE’s coronavirus vaccine in America.
Meanwhile, amid the new coronavirus strain scare, Moderna has said that it expects the immunity induced by its Covid-19 vaccine would be protective against the variant reported in the UK.